Iron deficiency and iron deficiency anemia (IDA) during pregnancy are risk factors for preterm delivery, prematurity, and small for gestational age birth weight. Iron deficiency has a negative effect on intelligence and behavioral development in the infant. It is essential to prevent iron deficiency in the fetus by preventing iron deficiency in the pregnant woman. The requirements for absorbed iron increase during pregnancy from ∼1.0 mg/day in the first trimester to 7.5 mg/day in the third trimester. More than 90% of Scandinavian women of reproductive age have a dietary iron intake below the recommended 15 mg/day. Among nonpregnant women of reproductive age, ∼40% have plasma ferritin ≤30 µg/l, i.e. an unfavorable iron status with respect to pregnancy. An adequate iron status during pregnancy implies body iron reserves ≧500 mg at conception, but only 15–20% of women have iron reserves of such a magnitude. Iron supplements during pregnancy reduce the prevalence of IDA. In Europe, IDA can be prevented by a general low-dose iron prophylaxis of 30–40 mg ferrous iron taken between meals from early pregnancy to delivery. In affluent societies, individual iron prophylaxis tailored by the ferritin concentration should be preferred to general prophylaxis. Suggested guidelines are: ferritin >70 µg/l, no iron supplements; ferritin 31–70 µg/l, 30–40 mg ferrous iron per day, and ferritin ≤30 µg/l, 60–80 mg ferrous iron per day. In women with ferritin <15 µg/l, i.e. depleted iron reserves and possible IDA, therapeutic doses of 100 mg ferrous iron per day should be advised.

Keywords:
Anemia, Iron deficiency, Ferritin, Hemoglobin, Iron, Pregnancy, Postpartum period
1.
Rowland TW, Deisroth MB, Green GM, Kelleher JF: The effect of iron therapy on the exercise capacity of non-anemic iron-deficient adolescent runners. Am J Dis Child 1988;142:165–169.
2.
Beard JL, Hendricks MK, Perez EM, Murray-Kolb LE, Berg A, Vernon-Feagans L, Irlam J, Isaacs W, Sive A, Tomlinson M: Maternal iron deficiency anemia affects postpartum emotions and cognition. J Nutr 2005;135:267–272.
3.
Milman N: Prepartum anemia: prevention and treatment. Ann Hematol 2008;87:949–951.
4.
Milman N, Byg KE, Ovesen L: Iron status in Danes updated 1994. II. Prevalence of iron deficiency and iron overload on 1319 women aged 40–70 years: influence of blood donation, alcohol intake, and iron supplementation. Ann Hematol 2000;79:612–621.
5.
Nybo M, Friis-Hansen L, Felding P, Milman N: Higher prevalence of anaemia among pregnant immigrant women compared to pregnant ethnic Danish women. Ann Hematol 2007;86:647–651.
6.
Milman N: Anemia – still a major health problem in many parts of the world! Ann Hematol 2011;90:369–377.
7.
Bothwell TH: Iron requirements in pregnancy and strategies to meet them. Am J Clin Nutr 2000;72:257S–264S.
8.
Milman N: Iron and pregnancy – a delicate balance. Ann Hematol 2006;85:559–565.
9.
Trygg K, Lund-Larsen K, Sandstad B, Hoffman HJ, Jacobsen G, Bakketeig LS: Do pregnant smokers eat differently from pregnant non-smokers? Pediatr Perinat Epidemiol 1995;9:307–319.
10.
Pedersen A, Fagt S, Groth MV, et al: Dietary habits in Denmark 2003–2008: main results. 2010. http://www.food.dtu.dk.
11.
Alwan NA, Greenwood DC, Simpson NAB, McArdle HJ, Godfrey KM, Cade JE: Dietary iron intake during early pregnancy and birth outcomes in a cohort of British women. Hum Reprod 2011;26:911–919.
12.
Hauner H, Vollhardt C, Schneider KT, Zimmermann A, Schuster T, Amann-Gassner U: The impact of nutritional fatty acids during pregnancy and lactation on early human adipose tissue development: rationale and design of the INFAT study. Ann Nutr Metab 2009;54:97–103.
13.
Milman N, Strandberg NS, Visfeldt J: Serum ferritin in healthy Danes: relation to marrow haemosiderin iron stores. Dan Med Bull 1983;30:115–120.
14.
Allen LH: Anemia and iron deficiency: effects on pregnancy outcome Am J Clin Nutr 2000;71:1280S–1284S.
15.
Lozoff B: Perinatal iron deficiency and the developing brain. Pediatr Res 2000;48:137–139.
16.
Grantham-McGregor S, Ani C: A review of studies on the effect of iron deficiency on cognitive development in children. J Nutr 2001;131:649S–666S.
17.
Beard JL: Why iron deficiency is important in infant development. J Nutr 2008;138:2534–2536.
18.
Cogswell ME, Parvanta I, Ickes L, Yip R, Brittenham GM: Iron supplementation during pregnancy, anemia and birth weight: a randomized controlled trial. Am J Clin Nutr 2003;78:773–781.
19.
Milman N: Postpartum anemia I: definition, prevalence, causes, and consequences. Ann Hematol 2011, DOI: 10.1007/s00277-011-1279-z.
20.
Vora M, Gruslin A: Erythropoietin in obstetrics. Obstet Gynecol Surv 1998;53:500–508.
21.
Murray-Kolb LE, Beard JL: Iron deficiency and child and maternal health. Am J Clin Nutr 2009:89:946S–950S.
22.
Milman N, Agger OA, Nielsen OJ: Iron supplementation during pregnancy: effect on iron status markers, serum erythropoietin and human placental lactogen – a placebo controlled study in 207 Danish women. Dan Med Bull 1991;38:471–476.
23.
Milman N, Bergholt T, Eriksen L, Byg KE, Graudal N, Pedersen P, Hertz J: Iron prophylaxis during pregnancy – how much iron is needed? A randomised, controlled study of 20 to 80 mg ferrous iron daily to pregnant women. Acta Obstet Gynecol Scand 2005;84:238–247.
24.
Cavill I: Iron and erythropoiesis in normal subjects and in pregnancy. J Perinat Med 1995;23:47–50.
25.
Milman N: Iron prophylaxis in pregnancy – general or individual and in which dose? Ann Hematol 2006;85:821–828.
26.
Pedersen P, Melsen GV, Milman N: Frequencies of the haemochromatosis gene (HFE) variants C282Y, H63D and S65C in 6,020 ethnic Danish men. Ann Hematol 2008;87:735–740.
27.
Wallace DF, Subramaniam VN: Non-HFE haemochromatosis. World J Gastroenterol 2007;13:4690–4698.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.